Kishida et al. reported that goshajinkigan suppressed sarcopenia via the IGF-1/insulin pathway, maintained the expression of mitochondrial-related transcription factors, and suppressed TNF-α in SAMP8 mice, indicating that goshajinkigan is a promising candidate for relief from sarcopenia (41). The gene discussed is IGF1; the disease is sarcopenia.